α-Synuclein regulation of the dopaminergic transporter:: a possible role in the pathogenesis of Parkinson's disease

被引:138
作者
Sidhu, A
Wersinger, C
Vernier, P
机构
[1] Georgetown Univ, Dept Pediat, Lab Mol Neurochem, Washington, DC 20007 USA
[2] CNRS, Inst Neurobiol Alfred FESSARD, F-91198 Gif Sur Yvette, France
关键词
dopamine transporter; alpha-synuclein; Parkinson's disease; synucleinopathies; 1-methyl-4-phenyl-1 2,3,6-tetrahydropyrimidine; neurodegeneration; Lewy bodies;
D O I
10.1016/j.febslet.2004.03.063
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) is a slow progressive neurodegenerative disorder. Recent evidence suggests a central role for alpha-synuclein, a protein of unknown function, in the genesis of PD. The phenomenon of selective degeneration of dopaminergic neurons in PD may be linked to the potential toxicity of dopamine itself and aberrations in the processes which regulate dopamine content may underlie the pathogenesis of this disease. Here, we review a vital role of alpha-synuclein in the modulation of dopamine transporter (DAT) function, and describe how disruption of this modulatory process permits increased re-uptake of high levels of intracellular dopamine by DAT, causing profound neurotoxicity. (C) 2004 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 53 条
[1]   Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism [J].
Bonifati, V ;
Rizzu, P ;
van Baren, MJ ;
Schaap, O ;
Breedveld, GJ ;
Krieger, E ;
Dekker, MCJ ;
Squitieri, F ;
Ibanez, P ;
Joosse, M ;
van Dongen, JW ;
Vanacore, N ;
van Swieten, JC ;
Brice, A ;
Meco, G ;
van Duijn, CM ;
Oostra, BA ;
Heutink, P .
SCIENCE, 2003, 299 (5604) :256-259
[2]   Absence of mutations in the coding region of the α-synuclein gene in pathologically proven Parkinson's disease [J].
Chan, P ;
Jiang, X ;
Forno, LS ;
Di Monte, DA ;
Tanner, CM ;
Langston, JW .
NEUROLOGY, 1998, 50 (04) :1136-1137
[3]   Structure and function of the dopamine transporter [J].
Chen, NH ;
Reith, MEA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 405 (1-3) :329-339
[4]  
Ciliax BJ, 1999, J COMP NEUROL, V409, P38, DOI 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO
[5]  
2-1
[6]  
Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.0.CO
[7]  
2-E
[8]   The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease [J].
Clayton, DF ;
George, JM .
TRENDS IN NEUROSCIENCES, 1998, 21 (06) :249-254
[9]   Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy [J].
Conway, KA ;
Lee, SJ ;
Rochet, JC ;
Ding, TT ;
Williamson, RE ;
Lansbury, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :571-576
[10]   Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct [J].
Conway, KA ;
Rochet, JC ;
Bieganski, RM ;
Lansbury, PT .
SCIENCE, 2001, 294 (5545) :1346-1349